Stokes is compounding Buprenorphine 0.5 mg/mL Injection in a 10 mL and 50 mL multi-dose vial. Stokes' Buprenorphine is independently tested for sterility and potency. A certificate of analysis is available upon request. Buprenorphine is compounded under both cGMP Standards and Stokes DEA Manufacturer License. Buprenorphine is Stokes' first 503B item and more items will be released in the coming weeks...stay tuned!